首页 >
法规速递
-
Document: COMP work plan 2025-2025/1/30
2025-02-05查看详情 > -
Document: European Shortages Monitoring Platform (ESMP): Implementation guide for marketing authorisation holders-2025/3/10
2025-03-11查看详情 > -
Document: QRD Appendix V - Adverse-drug-reaction reporting details-2025/4/9
2025-04-11查看详情 > -
Page: National competent authorities (human)-2025/5/22
2025-05-23查看详情 > -
Document: Guidance notes on the use of Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) terminology for reporting suspected adverse events in animals and humans - Rev.16-2025/6/27
2025-06-30查看详情 > -
Page: Aprepitant product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Disseminated Coccidioidomycosis: Developing Drugs for Treatment-2025/9/17
2025-09-18查看详情 > -
国家药监局关于复方公英胶囊转换为非处方药的公告（2025年第104号）-2025/10/24
2025-10-27查看详情 > -
Page: Type-IA variations: questions and answers-2025/11/26
2025-11-27查看详情 > -
Document: List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)-2025/12/17
2025-12-18查看详情 >
